U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H25ClN2OS.2ClH
Molecular Weight 473.887
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ZUCLOPENTHIXOL HYDROCHLORIDE

SMILES

Cl.Cl.OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1

InChI

InChIKey=LPWNZMIBFHMYMX-MHKBYHAFSA-N
InChI=1S/C22H25ClN2OS.2ClH/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26;;/h1-2,4-8,16,26H,3,9-15H2;2*1H/b18-5-;;

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including https://www.lundbeck.com/upload/au/files/pdf/Clopixol_CMI.pdf | https://www.ncbi.nlm.nih.gov/pubmed/26624987

Zuclopenthixol is indicated the management of the manifestations of schizophrenia and other mental illnesses with disturbances in thinking, emotional reactions and behaviour. It is also used to treat the manic phase of manic depressive illness. Zuclopenthixol, a thioxanthene derivative, has high affinity for both dopamine D1 receptors and dopamine D2 receptors. Zuclopenthixol also has high affinity for α1-adrenergic and 5-HT2 receptors. Zuclopenthixol (CLOPIXOL®) is avavilable in the form of tablets and solution for intramuscular injections.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CLOPIXOL

Approved Use

Zuclopenthixol is indicated the management of the manifestations of schizophrenia and other mental illnesses with disturbances in thinking, emotional reactions and behaviour. It is also used to treat the manic phase of manic depressive illness.
Primary
CLOPIXOL

Approved Use

Zuclopenthixol is indicated the management of the manifestations of schizophrenia and other mental illnesses with disturbances in thinking, emotional reactions and behaviour. It is also used to treat the manic phase of manic depressive illness.
PubMed

PubMed

TitleDatePubMed
Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime.
1987 Jan
Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia.
1991 Dec
Clozapine and weight gain.
2001 May
Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.
2014 May 15
Patents

Sample Use Guides

Clopixol tablets: The usual dose is 10 to 50 mg per day. Clopixol Acuphase injection: The usual dose is 50 to 150 mg (1 to 3 mL) every 2 to 3 days or as instructed by your doctor. Clopixol Depot injection: The usual dose is 200 to 400 mg (1 to 2 mL) every second to fourth week.
Route of Administration: Other
In Vitro Use Guide
Unknown
Name Type Language
ZUCLOPENTHIXOL HYDROCHLORIDE
MART.   WHO-DD  
Common Name English
Zuclopenthixol hydrochloride [WHO-DD]
Common Name English
NSC-329015
Code English
CLOPENTHIXOL CIS(Z)-FORM DIHYDROCHLORIDE [MI]
Common Name English
ZUCLOPENTHIXOL DIHYDROCHLORIDE
Common Name English
ZUCLOPENTHIXOL HYDROCHLORIDE [MART.]
Common Name English
CLOPENTHIXOL CIS(Z)-FORM DIHYDROCHLORIDE
MI  
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29710
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
Code System Code Type Description
CAS
58045-23-1
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
EPA CompTox
DTXSID5045332
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
NCI_THESAURUS
C95837
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
ECHA (EC/EINECS)
261-080-2
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
MERCK INDEX
m3653
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY Merck Index
RXCUI
102546
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY RxNorm
DRUG BANK
DBSALT000546
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
SMS_ID
100000085645
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
PUBCHEM
6433208
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
FDA UNII
7042692VYN
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
NSC
329015
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY
EVMPD
SUB05197MIG
Created by admin on Fri Dec 15 18:36:39 GMT 2023 , Edited by admin on Fri Dec 15 18:36:39 GMT 2023
PRIMARY